Tech Company Financing Transactions
Elutia Funding Round
Boston Scientific Corporation participated in a $8 million capital raise for Elutia. The financing round was announced on 10/1/2026.
Transaction Overview
Company Name
Announced On
10/1/2026
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Firstfield Road
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Website
Email Address
Overview
At Elutia, we are pioneering the future of patient care. Our proprietary drug-eluting biomaterial platform stands at the forefront of medical innovation. We are dedicated to solving the persistent challenges of traditional medical implants by integrating drugs, biologics and advanced science. Our focus is on creating solutions that improve patient outcomes, helping every patient not only recover but truly thrive.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Kevin Rakin
Chief Executive Officer
C. Randal Mills
Chief Financial Officer
Matthew Ferguson
Chief Scientific Officer
Michelle Williams
VP - Bus. Development
Sonali Fonseca
VP - Bus. Development
Peter Ligotti
VP - Finance
Jeff Hamet
VP - Human Resources
Tamara Grossett
Browse more venture capital transactions:
Prev: 10/1/2026: Daptic venture capital transaction
Next: 10/1/2026: Arceus venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs